PT  - JOURNAL ARTICLE
AU  - Aubergeon, Lucie
AU  - Baudin, Eric
AU  - Berruti, Alfredo
AU  - Grisanti, Salvatore
AU  - Oordt, CWillemien Menke-vander Houven van
AU  - Haak, Harm
AU  - Fassnacht, Martin
AU  - Capdevila, Jaume
AU  - Subbiah, Vivek
AU  - Jimenez, Camilo
AU  - Fouchardière, Christelle de la
AU  - Granberg, Dan
AU  - Kroiss, Matthias
AU  - Daugaard, Gedske
AU  - Toussaint, Hélène
AU  - Magalhaes, Joao Gamelas
AU  - Martinez, Jennifer
AU  - Belyn, Camille
AU  - Kervevan, Jerome
AU  - Ventujol, Chloé
AU  - Bonny, Christophe
AU  - Paillarse, Jean-Michel
AU  - Chene, Laurent
TI  - 630 EO2401, a new peptide immunotherapy against cancer, in combination with nivolumab, induces a strong and durable immune response in patients from the EOADR1–19/SPENCER study
AID  - 10.1136/jitc-2023-SITC2023.0630
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A719--A719
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A719.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A719.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.